| Catalog Number |
381033 |
| Health Effect - Clinical Code |
No Known Impact Or Consequence To Patient (2692)
|
| Date of Event |
11/27/2018
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
(b)(6).A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
|
| |
|
Event or Problem Description
|
|
It was reported that a bd insyte¿ autoguard¿ bc shielded iv catheter had a black smear on the needle tip or catheter tip.
|
| |
|
Additional Manufacturer Narrative
|
|
Investigation summary: dhr- the lot was built and packaged on afa line 11 from 31mar2018 through 04apr2018.All required challenge, set-up and in process samples were conducted and passed per specifications there were no qns initiated during the build of this lot.Received a 20ga unit with no packaging material.All components were present.Visual/microscopic evaluation: a black speck was observed on the catheter tubing (near the tip) of the unit received.The speck was loose (not embedded) and could be removed.Conclusion(s): the fm was identified as residual material introduced to the unit during the manufacturing process.A definite source of the particle could not be identified, it is possible to have originated from eva/k-resin that builds up on the bowls that feed up the material to the manufacturing machines.
|
| |
|
Event or Problem Description
|
|
It was reported that a bd insyte¿ autoguard¿ bc shielded iv catheter had a black smear on the needle tip or catheter tip.
|
| |
|
Search Alerts/Recalls
|